Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasticity of γδ T Cells: Impact on the Anti-Tumor Response.
Lafont V, Sanchez F, Laprevotte E, Michaud HA, Gros L, Eliaou JF, Bonnefoy N. Lafont V, et al. Among authors: bonnefoy n. Front Immunol. 2014 Dec 8;5:622. doi: 10.3389/fimmu.2014.00622. eCollection 2014. Front Immunol. 2014. PMID: 25538706 Free PMC article. Review.
PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody.
They L, Michaud HA, Becquart O, Lafont V, Guillot B, Boissière-Michot F, Jarlier M, Mollevi C, Eliaou JF, Bonnefoy N, Gros L. They L, et al. Among authors: bonnefoy n. Oncoimmunology. 2017 Jul 20;6(10):e1353857. doi: 10.1080/2162402X.2017.1353857. eCollection 2017. Oncoimmunology. 2017. PMID: 29123966 Free PMC article.
IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population.
Barjon C, Michaud HA, Fages A, Dejou C, Zampieri A, They L, Gennetier A, Sanchez F, Gros L, Eliaou JF, Bonnefoy N, Lafont V. Barjon C, et al. Among authors: bonnefoy n. Oncoimmunology. 2017 Oct 4;7(1):e1379642. doi: 10.1080/2162402X.2017.1379642. eCollection 2017. Oncoimmunology. 2017. PMID: 29296543 Free PMC article.
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.
Ashraf Y, Mansouri H, Laurent-Matha V, Alcaraz LB, Roger P, Guiu S, Derocq D, Robin G, Michaud HA, Delpech H, Jarlier M, Pugnière M, Robert B, Puel A, Martin L, Landomiel F, Bourquard T, Achour O, Fruitier-Arnaudin I, Pichard A, Deshayes E, Turtoi A, Poupon A, Simony-Lafontaine J, Boissière-Michot F, Pirot N, Bernex F, Jacot W, du Manoir S, Theillet C, Pouget JP, Navarro-Teulon I, Bonnefoy N, Pèlegrin A, Chardès T, Martineau P, Liaudet-Coopman E. Ashraf Y, et al. Among authors: bonnefoy n. J Immunother Cancer. 2019 Feb 4;7(1):29. doi: 10.1186/s40425-019-0498-z. J Immunother Cancer. 2019. PMID: 30717773 Free PMC article.
IL-21 Signaling in the Tumor Microenvironment.
Chabab G, Bonnefoy N, Lafont V. Chabab G, et al. Among authors: bonnefoy n. Adv Exp Med Biol. 2020;1240:73-82. doi: 10.1007/978-3-030-38315-2_6. Adv Exp Med Biol. 2020. PMID: 32060889 Review.
The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer.
Bastid J, Dejou C, Docquier A, Bonnefoy N. Bastid J, et al. Among authors: bonnefoy n. Front Immunol. 2020 Apr 21;11:718. doi: 10.3389/fimmu.2020.00718. eCollection 2020. Front Immunol. 2020. PMID: 32373132 Free PMC article. Review.
Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid Cancers.
Chabab G, Boissière-Michot F, Mollevi C, Ramos J, Lopez-Crapez E, Colombo PE, Jacot W, Bonnefoy N, Lafont V. Chabab G, et al. Among authors: bonnefoy n. Cells. 2020 Jun 24;9(6):1537. doi: 10.3390/cells9061537. Cells. 2020. PMID: 32599843 Free PMC article.
104 results